Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial

Fig. 3

Time to event curve in cumulative incidences of the components of primary endpoint (a) the composite of cardiac death, target vessel-related myocardial infarction. b Target lesion revascularization. Hazard ratios and P values are derived from Cox proportional hazard methods. CI confidence interval, HR hazard ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840